M

Marinus Pharmaceuticals
D

MRNS

0.23210
USD
-0.01
(-2.77%)
Market Open
Volume
2,501
EPS
-2
Div Yield
-
P/E
-0
Market Cap
12,808,583
OverviewSignalsIdeasNews
Related Instruments
    A
    ACAD
    -0.020
    (-0.12%)
    16.860 USD
    ALNY
    ALNY
    -7.255
    (-2.96%)
    238.250 USD
    B
    BPMC
    -0.980
    (-1.09%)
    89.140 USD
    I
    INSM
    -0.630
    (-0.89%)
    69.810 USD
    K
    KPTI
    -0.00480
    (-0.75%)
    0.63950 USD
    P
    PTCT
    -1.360
    (-2.94%)
    44.840 USD
    S
    SAGE
    -0.16000
    (-2.85%)
    5.45000 USD
    Z
    ZYNE
    0
    (0%)
    0.000000 USD
    More
News

Title: Marinus Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.